Home
Search results “Pharmaceutical companies liable for generic”
Rise of Generic Drug Prescriptions Creates Liability Nightmare
 
01:51
Under current law, generic drug manufacturers are less responsible for adverse reactions than brand-name manufacturers.
Views: 2003 ABC News
Are generic drugs being delayed to market?
 
10:00
Are less-expensive generic drugs being delayed to market by so-called "pay for delay" deals between drug companies? The deals happen after generic drug companies challenge the patents on brand-name drugs. The settlements include a date that the generic drug can enter the market, and in some cases, a payment from brand company to the generic company.
Views: 5457 PBS NewsHour
Rise of Generic Drug Prescriptions Creates Liability Nightmar
 
01:51
Under current law, generic drug manufacturers are less responsible for adverse reactions than brand-name manufacturers.
Views: 3 world news
The Real Deal: Generic Drug Companies Not Li
 
02:44
GLENVILLE -86% of Americans now take generic drugs and while those medications may be cheaper than the name brands, you're unknowingly giving up the ability to sue if you run into any unforeseen complications with the medication. Generic drug makers have to stick close to the name-brand formula and labeling and the Supreme Court has ruled because of those rules, they can't be held liable if something goes wrong. Debbie from Glenville has lasting effects from a drug reaction she suffered following a knee replacement, "I figured I'd come home and everything would be fine," she says but that's not what happened. She and her doctors say a generic pain medication she was taking caused renal failure and by the time she got back to the hospital, she was in serious condition. "At that point, I had 1,177 liters of urine throughout my body‚it was awful, I was so bloated I couldn't bend down to pick anything up, my legs ached, my ankles hurt, I couldn't do the therapy for my knee replacement," she says. After months of recovering, Debbie brought her case to a lawyer, "they said that you can't sue because it's a generic drug‚it took six months of my life away and they just say, "no, you can't do it, you can't sue," she says. Under federal law, generic drug makers are not allowed to change the safety warnings on their labels in response to new risks and side effects until after the name brand maker has done so. And then, the change needs to be approved by the FDA which creates a big window of time when patients may be taking the generic without updated health information. The FDA recently delayed a new rule that would require generic drug makers to independently update warnings after getting major pushback from the industry. The Generic Pharmaceutical Association argues the new rule would increase the prices of generic drugs and open up the generic drug makers to more liability. Debbie says she wouldn't mind paying a little extra for a little more piece of mind, "It was a nightmare and I don't want other people going through it," she says.
Views: 123 CBS6 Albany
Generic drug makers could be required to label side effects
 
01:43
If you suffered a dangerous side effect from a medication, you could sue the maker, unless it's a generic version. An FDA proposal, however, would protect patients by making generic drug companies more accountable.
Views: 123 WWLP-22News
I-Team: Generic Drug Legal Loophole
 
02:46
A family is fighting for better protection for consumers. WBZ-TV's Lauren Leamanczyk reports.
Views: 28 CBS Boston
Why are prices for generic drugs increasing?
 
02:57
Some generic drug prices are skyrocketing. ABC Action News looks into why and what customers can do about it.
Views: 719 ABC Action News
You Cannot Sue the Manufacturer of a Generic Drug - Cleveland Attorney Peter Brodhead Explains
 
03:05
You Cannot Sue the Manufacturer of a Generic Drug - Cleveland Attorney Peter Brodhead Explains http://www.spanglaw.com (877) 696-3303 Cleveland attorney Peter Brodhead talks about something that is very dangerous to the hundreds of thousands of people who take prescription drugs in this country. Every day, people take prescription drugs to cure, prevent or treat everything from a mild headache to cancer. On the market you have both a brand name drug and a generic version of the same drug which is offered a lower price point. You may be shocked to hear that if you take a generic drug you have absolutely no claim to a lawsuit if the drug is defective and caused you or your loved one harm. This is due to the fact that the generic drug has to develop and manufacture their drug in the closest possible way to the brand name drug -- they both contain the same chemical makeup. Because they have to follow the brand name drug company's formula, they are not liable for their own drugs that they produce. This was a decision upheld by the U.S. Supreme Court several times as the generic drug company has no other choice than to develop the same product and therefore they are not held responsible for your injuries. Watch the video to learn more. To learn more about defective drug law and my firm, visit our educational website at http://www.spanglaw.com. If you have legal questions, I want you to call me at (877) 696-3303. I welcome your call. Spangenberg Shibley & Liber LLP 1001 Lakeside Avenue East, Suite 1700 Cleveland, OH 44114 (877) 696-3303
11 Generic Manufacturers Approved to Sell Plavix as a Generic - NY Attorney Dan Burke Explains
 
02:49
11 Generic Manufacturers Approved to Sell Plavix as a Generic - NY Attorney Dan Burke explains more at: https://www.yourlawyer.com/defective-drug-attorneys/ Watch as attorney Dan Burke of Parker Waichman discusses how generic versions of the drug Plavix will soon be on the market. Used as a blood thinner, Plavix is a brand name drug that typically costs $200 a month for the prescription. Patients on the drug are being treated and prevented against blood clots. However, this drug has been flagged as being potentially harmful to patients. Patients and doctors are reported adverse effects such as bleeding events. Cases have been reported with patients experiencing bleeding in their lungs, stomach, and brain. So how does this affect the generic form? Well, generic form drugs are not allowed to change how the drug is made only offer it at a cheaper price. Because of this, you cannot go after the company if you are harmed by the drug as they are not responsible for the drug's faults. Sometimes trying to save money on a product does not equal to a good deal. Watch this video now to learn more. If you have additional questions about defective drugs, I want you to call me at (212) 267-6700. I welcome your call. Visit our website where you can view more videos and media content from our law firm. Parker Waichman LLP 59 Maiden Lane 6th Floor New York, NY 10038 (212) 267-6700 https://www.yourlawyer.com/new-york/
Views: 434 Parker Waichman
California court exposes drug makers to additional liability
 
03:20
California court exposes drug makers to additional liability. A sharply divided California Supreme Court ruled Thursday that pharmaceutical companies can be held liable for warning labels on generic versions of drugs they once made even after they've sold the drugs to other companies and stopped manufacturing them. The 4-3 decision was a victory for consumer advocates, but the pharmaceutical industry had argued that such a finding would stifle innovation and lead to extraneous warnings on drugs that could deter people from using them. In a dissenting opini... --------------------- DONT FORGET SUBSCRIBE FOR ME : https://goo.gl/VPm8QD
Views: 1 Current Affairs
HOW PRE-EMPTION OF CLAIMS AGAINST GENERICS IS AFFECTING PRODUCT LIABILITY LAW
 
17:11
TRIAL.COM - CHI2012 - Steve Imbriglia HOW PRE-EMPTION OF CLAIMS AGAINST GENERICS IS AFFECTING PRODUCT LIABILITY LAW Steve Imbriglia (Gibbons; Philadelphia, PA) presents at the The Network of Trial Law Firms' Litigation Management CLE SuperCourse: Trial lawyer Steve Imbriglia shows how trial lawyers are attempting to circumvent a recent Supreme Court decision pre-empting claims against manufacturers of generic drugs and describes the impact of those efforts on product litigation generally. Brand name manufacturers are being targeted for liability resulting from plaintiffs' use of generic products. Materials: http://www.trial.com/cle/materials/2012-ch/imbriglia.pdf PowerPoint: http://www.trial.com/cle/powerpoints/2012-ch/imbriglia.pdf
AMA Warns Docs: Pay for Switches to Generics Risky
 
02:53
Physicians who switch patients from a brand name drug to generic drugs could face criminal charges. AMA says that a physician who accepts payments from an insurer for switching a patient from brand name drugs to a generic drug "could potentially face both criminal and civil liability exposure under the federal anti-kickback statute."
Views: 484 nossline
Generic drugs don't necessarily mean low prices
 
10:19
NewsHour Weekend Megan Thompson reports on the surprising disparity in pricing for generic drugs. Generics, generally thought to be cheap, can actually vary widely in price from pharmacy to pharmacy, causing some to skip medications altogether.
Views: 5321 PBS NewsHour
Generic Drugs vs Brand Name Drugs
 
01:01
If you suffer a side effect from your medication, if you're taking a generic drug, you can't file a lawsuit for personal injury. Only the name brand drug company has to monitor safety and update warnings. The generic drug companies only have to be the same as the name brand drug company, and therefore they have no responsibility to consumers. About 80% of the drugs sold in the US are generic, so currently, the drug manufacturers for 80% of the US are not under requirement to look out for patient safety and update their warnings. However, the FDA is looking at passing new regulations that would change the standards for generic companies. This has been the Legal Minute, brought to you by BurgSimpson - Good Lawyers. Changing Lives. 1-800-BURG-4-LAW 1-800-287-4529 http://www.burgsimpsonohio.com
Views: 763 BurgSimpson
Generic Vs Branded Drugs
 
02:54
There are a lot of myths and misconceptions surrounding Generic Drugs. This infographic is created by MHC Asia Group for MHC Medical Network to educate its clients and help them make informed decisions. Good public health education can help companies work towards a more cost-effective healthcare solutions. Disclaimer: The information contained inside this infographic is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the infographic or the information, products, services or related graphics contained inside the infographic for any purposes. In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this infographic. Music license certificate #19634 from Bensound.com
Views: 46461 MHC Corporate
Supreme Court hearing generic drug maker liability case
 
01:38
The U.S. Supreme Court is hearing arguments in the case of a New Hampshire woman who was critically injured after taking a generic drug for shoulder pain. The justices are looking at whether the generic drug maker is responsible for a medication that, by law, must be an exact copy of the original name brand drug. Tara Mergener reports.
Views: 45 FastTheLatestNews1
What Are Generic Medicines?
 
04:24
What Are Generic Medicines? Generic medicines are exact copies of popular brand-name drugs, they have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety, and the strength as the original drug.  TO CONSULT: https://www.wellinghomeopathy.com/ FACEBOOK: https://www.facebook.com/Dr.Welling.MD TWITTER: https://twitter.com/dr_Welling YOUTUBE: https://www.youtube.com/channel/UCyJz4o-WtwHJxiO2_4O1ppw TO CONSULT: https://www.wellinghomeopathy.com/ FACEBOOK: https://www.facebook.com/Dr.Welling.MD TWITTER: https://twitter.com/dr_Welling YOUTUBE: https://www.youtube.com/channel/UCyJz4o-WtwHJxiO2_4O1ppw For Communication: Welling Homeopathy Clinics. Corporate Office: 1st Floor, Shraddha Complex, Old Nagardas Road, Near Andheri (e) Metro Station, Opp Classic Restaurant, Mumbai 400069. A Welling Healthcare Pvt. Ltd. brand. ( an ISO:9001 company )  Patient Helpdesk (+91) 80-80-850-950 Awarded the International Star Award for Quality in Healthcare at Geneva Quality Convention 2012 This video is not designed to and does not provide medical advice, professional diagnosis, opinion, treatment or services to you or to any other individual. Through my videos, blog posts, website information, I give suggestions for you and your doctor to research and provide general information for educational purposes only. The information provided in this video or site, or through linkages to other sites, is not a substitute for medical or professional care, and you should not use the information in place of a visit, call consultation or the advice of your physician or other healthcare provider. Welling Healthcare Private Limited, Welling Homeopathy Clinics & Dr.Welling,M.D. are not liable or responsible for any advice, course of treatment, diagnosis or any other information, services or product you obtain through this video or site.
Views: 5750 Dr.Welling,M.D. Show
Popular drugs in line to go generic
 
01:55
In the next 14 months, seven of the world's 20 best-selling drugs will be available in generic form. Jeff Glor reports on the expiration of drug patents and what it means for consumers.
Views: 438 CBS
The Pharmaceutical Pride of West Africa
 
12:09
Danadams Pharmaceuticals Industry Limited is a wholly-Ghanaian owned limited liability company incorporated in Ghana. Danadams was commissioned on 8th June 2005 by then President John Kufour, who noted that the company would be strategic for Ghana in its fight against endemic diseases. From its original staff strength of fifty-two, Danadams now employs over 250 employees, and is delivering on its promise to contribute to the growth and impact of the local manufacturing pharmaceutical industry in Africa. Danadams' mission is to lead Africa for best-in-class, quality, safe and efficacious pharmaceuticals at affordable prices -- developed, manufactured, and distributed by Africans. Our core business is the production of anti-retroviral, anti-malarial, anti-tuberculosis and other quality generic pharmaceuticals used to fight opportunistic infections in HIV/AIDS patients. Danadams in particular seeks to address the problem of scarcity of anti-retroviral (ARV) drugs in Ghana and the rest of West Africa, by increasing its production of quality generic ARV drugs locally, and as from 2011, collaborating with strategic partners to develop new pediatric ARV drugs especially for the African market. Moreover, Danadams is among other West African Pharmaceutical companies selected to collectively act as catalysts to spearhead the building of the local capacity for production and distribution of ARV drugs. It is working in partnership with governmental initiatives like the Food and Drugs Board (FDB), economic regional bodies such as West African Health Organization (WAHO) under ECOWAS, and international organizations like the United Nations Industrial Development Organization (UNIDO) and World Health Organization (WHO).
Views: 2953 Danadams Gh
Dangerous Drugs News: Generic Drugs May Be Liable For Injuries In the Near Future
 
01:05
Visit http://www.rotlaw.com/lawsuits/dangerous-drugs/ for more information on dangerous drugs. The Supreme Court of the United States is hearing arguments this week in a case that could give patients injured by generic medications the right to sue. Currently, only original manufacturers can be held liable for harms caused by prescription medications. Karen Barrett of New Hampshire sued Mutual Pharmaceuticals of Philadelphia after she went blind and her skin began to fall off following her use of the generic drug Sulindac, which the company manufactures. A jury awarded her 21 million dollars. An appeals court upheld the verdict and the award. If the Supreme Court upholds the ruling of the lower courts, it would open the door for claims against generic drug manufacturers, who are by federal law required to reproduce the original design and labeling of a brand-name drug. The Rottenstein Law Group encourages patients to visit http://www.rotlaw.com/lawsuits/dangerous-drugs/ for more updates on the Supreme Court trial and for more information on dangerous drugs. Rottenstein Law Group, LLP 321 W 44th St # 804 New York, NY 10036 (212) 933-9500 http://www.youtube.com/watch?v=HC7djvoyWaA
Views: 522 RotlawNewsDesk
Are Generic Drugs Getting a Free Pass?
 
29:23
Should consumers have less legal protection if they become injured taking a generic drug instead of a brand name? The U.S. Supreme Court may answer that once and for all this year. The American Law Journal presents "Are Generic Drug Manufacturers Getting a Free Pass?" The panel looks at U.S. Supreme Court cases (Pliva v. Mensing, the recent Mutual Pharmaceutical v. Bartlett) and beyond (Alabama's Wyeth v. Weeks). Joining host Christopher Naughton are Philadelphia attorneys Claudine Q. Homolash, of Sheller, P.C. representing plaintiffs, pharma defense attorney Terry M. Henry, Blank Rome LLP. Joining the discussion are Paul Langevin, M.D., anesthesiologist at Hahnemann University Hospital and Kate Greenwood, Research Fellow and Lecturer for Seton Hall Law's Center for Pharmaceutical Law & Policy. Program 1317. For more information, visit LawJournalTV.com
Should Big Pharma be Protected Against Law Suits for Unlabelled Side Effects?
 
04:35
In 2011 there was a US Supreme Court ruling that pharmaceutical companies making drugs during the life of their patent are liable for inadequate safety warnings on the label of the drug. In June of 2013 the same court ruled that generic drug producers were NOT liable for law suits related to adverse drug reactions not printed on the label so long as they are not purposefully being withheld. This federal law supercedes any state laws to the contrary. Of course this is a blow to patient safety as generic drug makers would no longer have incentive to monitor the safety of their products. For more information please visit www.doctorsaputo.com
Views: 107 DoctorSaputo
Generic Drug Stocks
 
04:39
http://profitableinvestingtips.com/investing-tips/generic-drug-stocks Generic Drug Stocks By www.ProfitableInvestingTips.com. Pharmaceutical companies that make generic drugs were once a niche market. Today generic drug companies are set to bypass the makers of brand name drugs in sales value and volume according to About Money. Just a few years ago generic drug makers owned just a small slice of the pharmaceutical drug market. Today generics are a formidable segment of the industry and are on track to surpass branded drugs in sales value as well as sales volume within a few years, according to industry analysts. In the United States - where about 80 percent of all scripts written are for generics -- and traditional markets in Europe, multinational branded firms feeling losses from the patent cliff, health care reform legislation and austerity, are forming partnerships with their generic competitors to tap the expansion in generic sales. The top worldwide generic drug stocks and their 2012 generic drug sales are the following: • Teva, $10.4 billion • Mylan, $5.8 billion • Hospira, $4.1 billion • Sanofi, €1.8 billion • Ranbaxy Laboratories Ltd., $2.3 billion • Aspen Pharmacare Holding Ltd., 15.3 billion rand • STADA Arzneimittel AG, €1.2 billion Teva is the clear leader and Teva wants to take over Mylan. Teva to Acquire Mylan The New York Times reports that two generic drug stocks may become one as Teva seeks to acquire its rival Mylan. The deal making reached a fevered pitch on Tuesday when Teva, an Israeli maker of generic drugs, made an unsolicited $40 billion offer for Mylan, a rival based in the Netherlands. Getting bigger gives you better pricing and better leverage and also gets you into more markets.” This is especially true for generic drug makers, which rely less on research and development and more on maximizing profits from increasingly large global operations. Teva makes the case that by taking over Mylan they will add to their lead among generic drug stocks and increase annual revenue to around $30 billion as well as realize about $2 billion in cost savings. What Are Generic Drug Stocks? The Food and Drug Administration defines generic drugs. A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to a brand/reference listed drug product in dosage form, strength, quality and performance characteristics, and intended use." And generic drugs are cheaper than brand name drugs. This is because generic drug companies do not have the same research and development costs that big pharmaceutical companies have. They simply wait for the patent to expire on new blockbuster medications and make an identical medication for much less money. There are all sorts of new miracle drugs in the world and they are simply too expensive for the vast majority of people who take them. Generic drug stocks prosper because they provide necessary medications for the likes of the aging of populations in North America, Europe and Japan which increase their prescribed drug consumption every year. Should You Invest in Generic Drug Stocks? No matter how attractive generic drug stocks may seem fundamental stock analysis will tell you if a stock or a pending deal has good intrinsic value or not. There are pitfalls that Teva could fall into and not succeed in acquiring Mylan. These are antitrust concerns and a Mylan poison pill. If you are interested in generic drug stocks do your homework first. http://youtu.be/N113JpVAxok
Views: 241 InvestingTip
Courts weigh in on generic drug delays
 
11:22
Are less-expensive generic drugs being delayed to market by so-called "pay for delay" deals between drug companies? That's the allegation of the Federal Trade Commission, which has made fighting the deals one of its top priorities. NewsHour Weekend correspondent Megan Thompson spoke to Ed Silverman who writes the Pharmalot Blog for the Wall Street Journal, and has covered the pharmaceutical industry for almost 20 years.
Views: 794 PBS NewsHour
Generic Drugs & Right to Sue: Atty. Matt Harman comments
 
00:36
Are you at liberty to sue if you are harmed by a generic drug? Attorney Matt Harman of Harman Law, LLC in Atlanta, GA comments. For more information, visit HarmanLaw.com.
Views: 62 Harman Law Firm
Generic Drug Prices On The Rise
 
02:19
Doctors are starting to nice a sharp increase in the price of generic drugs. WBZ-TV's Dr. Mallika Marshall reports. Read more recent News stories: http://cbsboston.com SUBSCRIBE TO THE CBS BOSTON YOUTUBE CHANNEL: https://www.youtube.com/user/CBSBostonWBZ
Views: 681 CBS Boston
Generic Lipitor Warning: Manufacturer Halts Production of Drug
 
01:30
David Kerley looks into production problems in generic form of cholesterol drug.
Views: 1680 ABC News
Big Pharma’s Price Gouging Days Could Soon Be Over
 
00:55
Via America's Lawyer: Mike Papantonio talks about the fight between attorney generals nationwide and pharmaceutical companies price fixing of generic drugs. Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Order Mike Papantonio's new novel Law and Disorder today: https://www.amazon.com/Law-Disorder-Mike-Papantonio/dp/1590793676 Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com Support Ring of Fire by subscribing to our YouTube channel: https://www.youtube.com/user/golefttv?sub_confirmation=1 Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/
Views: 3088 The Ring of Fire
ALERT: Generic Drug Companies Cannot Be Sued For Failure to Warn
 
00:46
If you took a generic drug and you believe you or a loved one were injured as a result, you may be eligible for compensation. Speak to a lawyer about protecting your legal rights. The consultation is free. Burg Simpson lawyer Janet Abaray can help: 1-800-713-9340. ************************************************** Considering a lawyer? Not sure if you have a case? Knowing your rights can be intimidating and confusing. That's why Burg Simpson's lawyers have created a vast archive of answers to your most pressing legal questions: http://www.burgsimpson.com/blogfeeds.html And if you can't find the answer you're looking for, give us a call. We can help. Burg Simpson 1-800-713-9340
Views: 132 BurgSimpson
Supreme Court to Hear Generic Drug Appeal [audio]
 
12:29
Nov. 8 (Bloomberg Law) -- The U.S. Supreme Court will hear the oral arguments in a case between Novo Nordisk A/S, the manufacturer of diabetes drug Prandin, and generic drug maker Caraco Pharmaceutical Laboratories, Ltd. The legal dispute, over the manufacture of a generic version of the drug, centers on interpretation of the Hatch-Waxman Act and could change how brand-name drug makers use patent law. Tony Dutra, legal editor of BNA's Patent, Trademark & Copyright Journal, talks with Bloomberg Law's Josh Block about the case which will be argued before the Court on Dec. 5. https://www.bloomberglaw.com Follow on Twitter: @BloombergLaw @JoshBlock560
Views: 439 Bloomberg Law
Generic Drugs & Right to Sue - Atty. Stephen Sheller comments
 
01:29
Atty. Stephen Sheller of Sheller, P.C. comments on your right to sue regarding generic drugs vs. brand-name drugs. For more information, visit Sheller.com.
Views: 57 Sheller, PC
LLC Generic 1
 
05:01
Views: 27 Albert Tan
Consumers Could Be Paying Too Much For Generic Medication | NBC Nightly News
 
02:10
The $75 billion industry is supposed to keep medication prices low, but a new lawsuit filed by 46 Attorneys General alleges price fixing to charge more. » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and original digital videos. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: http://nbcnews.to/ReadNBC Find NBC News on Facebook: http://nbcnews.to/LikeNBC Follow NBC News on Twitter: http://nbcnews.to/FollowNBC Follow NBC News on Google+: http://nbcnews.to/PlusNBC Follow NBC News on Instagram: http://nbcnews.to/InstaNBC Follow NBC News on Pinterest: http://nbcnews.to/PinNBC Consumers Could Be Paying Too Much For Generic Medication | NBC Nightly News
Views: 736 NBC News
Generic Drugs Free From Federal Regulations - The Ring Of Fire
 
06:45
The US Supreme Court recently gave generic drug manufacturers a free pass to poison and kill American consumers. But even before that ruling, generic drug companies were subject to few, if any, federal regulations. Ring of Fire guest host Farron Cousins discusses this with attorney Howard Nations. Watch Ring of Fire every Sunday at 12pm Eastern/9am Pacific on Free Speech TV! Follow more of our stories at http://www.RingofFireRadio.com Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557
Views: 430 The Ring of Fire
Supreme Court Rules in Favor of Generic  Drug Preemption
 
04:22
The United States Supreme Court held in Pliva, Inc. v. Mensing that federal drug labeling laws directly conflict with, and therefore impliedly preempt, state law failure-to-warn claims against generic drug manufacturers. Mensing is the latest in a series of federal preemption cases involving the pharmaceutical and medical device industry
Views: 278 tcdevoto
Consumer Report with Brand and Generic Drugs
 
02:04
Consumer Report-Brand and Generic Drugs. Reporter Shaun Gallagher, edited by Shaun Gallagher & Dan Koob.
Views: 302 Shaun Gallagher
Doctors violating MCI guidelines in prescribing drugs with generic name
 
02:18
Doctors violating MCI guidelines in prescribing drugs with generic name
Views: 147 ETV Andhra Pradesh
Leibowitz Says FTC Working to Stop Generic Drug Delays
 
04:00
May 4 (Bloomberg) -- Jon Leibowitz, chairman of the U.S. Federal Trade Commission, talks about the FTC's attempts stop drug-company deals that delay the introduction of generic drugs. Leibowitz, who spoke yesterday with Bloomberg's Erik Schatzker, also talks about antitrust laws. (This is an excerpt of the full interview. Source: Bloomberg)
Views: 70 Bloomberg
Attorney Stewart Eisenberg Comments on the Safety of Generic Drugs
 
04:15
Stewart Eisenberg appeared on The American Law Journal to explain why people have less legal protection when harmed by a generic drug.
Views: 34 Kenneth Rothweiler
Can Drug Companies be Sued for Failure to Warn?
 
01:32
Drug companies are not only responsible to consumers for producing medications that are reasonably safe, but they must also warn people of certain risks. In this video, Philadelphia drug injury lawyer Daniel Jeck discusses product liability for pharmaceutical corporations. In a case he handled, he was successful in a lawsuit whereby the drug company did not warn women that taking a certain hormone increased their risk of breast cancer.
Failure to Warn for Generic Drugs - Atty. Claudine Homolash comments
 
00:50
Atty. Claudine Homolash discusses failure to warn injury claims for generic drugs. From The American Law Journal, aired 2013 on Philadelphia CNN-News affiliate WFMZ-TV. For more information, visit CQHFirm.com.
Views: 68 Claudine Homolash
Generic Drugs Just Got More Dangerous - The Ring Of Fire
 
12:15
The FDA was supposed to issue new rules last year to make generic prescription drugs safer for American consumers. But so far, they’ve failed to take any action, which is leaving patients at risk and drug makers with a Get Out of Jail Free card. Ring of Fire’s Farron Cousins discusses this with attorney Howard Nations. Listen to Ring of Fire on Saturdays from 3pm - 6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn: http://tunein.com/radio/Progressive-Voices-s189055/ Or find a station here: http://www.ringoffireradio.com/station/ Watch Ring of Fire every Sunday at 12pm Eastern/9am Pacific on Free Speech TV! Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv You can also support us here: http://www.ringoffireradio.com/support/ Your continued support keeps Ring of Fire on the air! Follow more of our stories at http://www.RingofFireRadio.com Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Support us further by shopping on Amazon via our Amazon-Ring of Fire partnership link. A portion of the sales will come back to Ring of Fire at no extra cost to you. Bookmark and follow the link below and continue shopping as usual! Amazon - Ring of Fire partnership link: http://www.amazon.com/?tag=rinoffir-20
Views: 2279 The Ring of Fire
Big victory for generic drug makers in Indian courts- VOA60 World
 
01:10
India: Big victory for generic drug makers as Supreme Court rejects patent bid by Swiss drug firm Novartis for cancer drug.   Tunisia: Activists call for greater social justice as World Social Forum closes in Tunisia.   Egypt:  Popular satirist Bassem Youssef is released on bail after allegations he insulted Islam and President Morsi.   Mauritius: Monday declared day of national mourning after flash floods kill at least 10.  Chile: Thousands rally in Santiago for gay rights.     Japan: Eighty-year-old mountain climber Yiuchiro Miura is set to try to break world record for the oldest man to climb Mount Everest.
Views: 518 VOA60NEWS
FreeHailEstimate.com "Generic March 2013"
 
00:32
This commercial was edited for FreeHailEstimate.com by J.C. Bowers at Campfire Creative in Oklahoma City. Hail footage provided by Stewart Mayer. Information and offers in this commercial may no longer be valid. Campfire Creative, LLC, an independent commercial production company. Contact J.C. at 405-863-1480
Views: 21 CampfireCreative
What is MARKET SHARE LIABILITY? What does MARKET SHARE LIABILITY mean?
 
04:52
What is MARKET SHARE LIABILITY? What does MARKET SHARE LIABILITY mean? MARKET SHARE LIABILITY meaning - MARKET SHARE LIABILITY definition - MARKET SHARE LIABILITY explanation. Source: Wikipedia.org article, adapted under https://creativecommons.org/licenses/by-sa/3.0/ license. SUBSCRIBE to our Google Earth flights channel - https://www.youtube.com/channel/UC6UuCPh7GrXznZi0Hz2YQnQ Market share liability is a legal doctrine that allows a plaintiff to establish a prima facie case against a group of product manufacturers for an injury caused by a product, even when the plaintiff does not know from which defendant the product originated. The doctrine is unique to the law of the United States and apportions liability among the manufacturers according to their share of the market for the product giving rise to the plaintiff's injury. Market share liability was introduced in the California case Sindell v. Abbott Laboratories. In Sindell, the plaintiffs were injured by DES, a drug prescribed to prevent miscarriage. The mothers of the plaintiffs had taken DES while pregnant, and expert testimony showed this to be a proximate cause of reproductive tract cancers in the plaintiffs years later. The plaintiffs, however, could not ascertain which drug company distributed the DES taken by their mothers. The court responded by allowing the plaintiffs to apportion liability among the defendant drug companies according to their respective shares in the DES market. Sindell laid out the requirements for applying the doctrine of market share liability: First, the defendants in court must constitute substantially all of the market. This is a distinguishing factor from alternative liability, which requires that all of the defendants be in court (See Summers v. Tice). Having "substantially all" of the market makes it more likely that the actual wrongdoer will be in court. A main reason for not requiring all of the relevant market is that as time passes, some manufacturers drop out of the market, and it would raise the bar for the plaintiff too high. Also if all defendants were present, then market share liability would be unnecessary, because the plaintiff would be able to apply the doctrine of alternative liability to put the burden of proving causation onto the defendants. Second, the products must be fungible (i.e. interchangeable—they must be of the same composition). For example, in Skipworth v. Lead Industries Association, the court found the lead paint sold by the defendants to not be fungible because the paints had lead pigments containing different chemical formulations, different amounts of lead, and differed in potential toxicity. Third, the defendants (potential tortfeasors) must all have been in the market within the specific timeframe surrounding the incident. Fourth, the inability to point to a specific tortfeasor must not be the plaintiff's fault. This is particularly relevant in the pharmaceuticals context, as most plaintiffs are prescribed generic drugs and thus have no knowledge of who manufactured the product. Jurisdictions and courts differ on the possibilities open to defendants to absolve themselves of market share liability. In Sindell (California), the court allowed defendants to bring forth exculpatory evidence and thus free themselves of liability. However, in Hymowitz v. Eli Lilly & Co. (New York), the court refused to allow exculpatory evidence because it felt that doing so would undermine the theory underpinning market share liability—because liability is based on relevant market share, providing exculpatory evidence will not reduce a defendant's overall share of the market. Sindell required plaintiffs to join defendant drug companies in a single action. A Wisconsin court took a different approach on this issue in Collins v. Eli Lilly Co. In Collins, the court found that the plaintiff could bring a cause of action against a single defendant, and the burden of proof would be shifted to the defendant to show that they did not produce the DES taken by the plaintiff's mother. Efforts to expand the market share approach beyond DES cases have been mostly rejected because the strict requirements of applying market share liability. Courts have declined to expand the market-share approach to asbestos (Becker v. Baron Bros.), handguns (Hamilton v. Beretta), and lead paint (Santiago v. Sherwin Williams Co.). The market-share approach has been expanded to cases involving MTBE in the New York case In re Methyl Tertiary Butyl Ether.
Views: 191 The Audiopedia
Another US Supreme Court Ruling in Favor of Drug Companies: Generic Companies Hide Patient Risks
 
02:14
More information on PLIVA v Mensing case regarding FDA labels: http://www.msnbc.msn.com/id/43526608/ns/health-health_care/
Views: 87 NewsBanana
Karen Bartlett's Fight for Accountability
 
03:14
Karen's prescription was filled with a generic drug, not a brand, now her legal rights are in question. The U.S. Supreme Court will hear Karen's case, Mutual Pharmaceutical v. Bartlett, today about the legal responsibility generic manufacturer's have for the safety of their drug. For more information, visit www.TakeJusticeBack.com/GenericDrugs
Views: 1165 Take Justice Back
Zieve: FDA Approval and Preemption of Products Liability Claims
 
12:14
Allison M. Zieve, of the Public Citizen Litigation Group, addresses the panel on "FDA Approval and Preemption of Products Liability Claims," at the Judicial Symposium on The Pharmaceutical Industry: Economics, Regulation, and Legal Issues, hosted by the Northwestern Law Judicial Education Program in May 2009.
Views: 138 NorthwesternU